Renovia

About:

Renovia was a developer of prescription digital therapeutics for pelvic floor disorders. Renovia ceased operations in late 2022.

Website: https://renoviainc.com/

Top Investors: Cormorant Asset Management, Western Technology Investment, Perceptive Advisors, Ascension Ventures, Longwood Fund

Description:

Renovia was a developer of prescription digital therapeutics for pelvic floor disorders. Renovia ceased operations in late 2022 after its investors conducted a strategic review including considering a sale of the company. In January 2023, substantially all the assets of the company, including its intellectual property, were sold to Axena Health, Inc.